These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26028647)

  • 1. Control of asthma in real life: still a valuable goal?
    Papaioannou AI; Kostikas K; Zervas E; Kolilekas L; Papiris S; Gaga M
    Eur Respir Rev; 2015 Jun; 24(136):361-9. PubMed ID: 26028647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The misuse of asthma drugs.
    Colice GL
    Expert Rev Respir Med; 2013 Jun; 7(3):307-20. PubMed ID: 23734651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring asthma in childhood.
    Lødrup Carlsen KC; Pijnenburg MW;
    Eur Respir Rev; 2015 Jun; 24(136):178-86. PubMed ID: 26028630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring asthma in childhood: symptoms, exacerbations and quality of life.
    Brand PL; Mäkelä MJ; Szefler SJ; Frischer T; Price D;
    Eur Respir Rev; 2015 Jun; 24(136):187-93. PubMed ID: 26028631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK): study protocol for a pragmatic, cluster randomised trial with nested health economic and process evaluations.
    Smith JR; Musgrave S; Payerne E; Noble M; Sims EJ; Clark AB; Barton G; Pinnock H; Sheikh A; Wilson AM;
    Trials; 2018 Aug; 19(1):466. PubMed ID: 30157917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study.
    Braido F; Brusselle G; Guastalla D; Ingrassia E; Nicolini G; Price D; Roche N; Soriano JB; Worth H;
    Respir Res; 2016 May; 17(1):51. PubMed ID: 27179604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on the Management of Severe Asthma.
    Siddiqui A; Kopas L
    Methodist Debakey Cardiovasc J; 2017; 13(2):82-83. PubMed ID: 28740590
    [No Abstract]   [Full Text] [Related]  

  • 8. Mepolizumab (Nucala) for severe eosinophilic asthma.
    Med Lett Drugs Ther; 2016 Jan; 58(1486):11-2. PubMed ID: 26761344
    [No Abstract]   [Full Text] [Related]  

  • 9. Steroid response in refractory asthmatics.
    Jang AS
    Korean J Intern Med; 2012 Jun; 27(2):143-8. PubMed ID: 22707883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on paediatric asthma.
    Hedlin G; Konradsen J; Bush A
    Eur Respir Rev; 2012 Sep; 21(125):175-85. PubMed ID: 22941882
    [No Abstract]   [Full Text] [Related]  

  • 11. Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
    Silkoff PE; Strambu I; Laviolette M; Singh D; FitzGerald JM; Lam S; Kelsen S; Eich A; Ludwig-Sengpiel A; Hupp GC; Backer V; Porsbjerg C; Girodet PO; Berger P; Leigh R; Kline JN; Dransfield M; Calhoun W; Hussaini A; Khatri S; Chanez P; Susulic VS; Barnathan ES; Curran M; Das AM; Brodmerkel C; Baribaud F; Loza MJ
    Respir Res; 2015 Nov; 16():142. PubMed ID: 26576744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.
    Chipps BE; Zeiger RS; Borish L; Wenzel SE; Yegin A; Hayden ML; Miller DP; Bleecker ER; Simons FE; Szefler SJ; Weiss ST; Haselkorn T;
    J Allergy Clin Immunol; 2012 Aug; 130(2):332-42.e10. PubMed ID: 22694932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Severe Asthma in the Era of Biologic Treatments.
    Teague WG
    Pediatr Allergy Immunol Pulmonol; 2020 Sep; 33(3):118-120. PubMed ID: 32953228
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe refractory asthma: an update.
    Wener RR; Bel EH
    Eur Respir Rev; 2013 Sep; 22(129):227-35. PubMed ID: 23997049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain.
    Sicras-Mainar A; Capel M; Navarro-Artieda R; Nuevo J; Orellana M; Resler G
    J Med Econ; 2020 May; 23(5):492-500. PubMed ID: 31958257
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring asthma in childhood: management-related issues.
    Rottier BL; Eber E; Hedlin G; Turner S; Wooler E; Mantzourani E; Kulkarni N;
    Eur Respir Rev; 2015 Jun; 24(136):194-203. PubMed ID: 26028632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Asthma--between "control" and "severity"].
    Mihălţan F
    Pneumologia; 2008; 57(4):192-3. PubMed ID: 19186680
    [No Abstract]   [Full Text] [Related]  

  • 18. [On general practitioners' care of patients with asthma].
    Von Voshaar T; Behr J; Brüggenjürgen B; Deimling A; Krüger M; Virchow C; Wiens C
    MMW Fortschr Med; 2012 Apr; 154 Suppl 1():1-7. PubMed ID: 23427362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe T2-high asthma in the biologics era: European experts' opinion.
    Pavord I; Bahmer T; Braido F; Cosío BG; Humbert M; Idzko M; Adamek L
    Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalised medicine in asthma: time for action: Number 1 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.
    Chung KF
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.